Breast Lesion Localization Methods Market Size and Share Is Expected To Exhibit a CAGR Of 10.7% By 2027

Global Breast Lesion Localization Methods Market

The global breast lesion localization methods market was valued at US$ 530.2 million in 2018 and is projected to exhibit a staggering CAGR of 10.7% over the forecast period (2019-2027). 

Rising prevalence of breast cancer is foreseen to propel the growth of the global breast lesion localization methods market in the forthcoming years. According to a WHO report published in 2018, breast cancer is the most frequently diagnosed cancer type among women, affecting approximately 2.1 million women around the globe each year. As estimated, around 627,000 women die of breast cancer, accounting for 15% of all cancer deaths among women.

Request for the trending sample of this report: https://www.coherentmarketinsights.com/insight/request-sample/104

Increasing government initiatives aimed at propagating awareness about breast cancer across developed, as well as emerging regions of the world, is a vital growth aspect for the global breast lesion localization methods market. According to The Pink Initiative and Breast Cancer Statistics in India, in 2014, a significantly large patient population, aged below 50 years, suffered from breast cancer. Thus, rising patient population in those regions offers lucrative opportunities to the market players there to manufacture highly effective products for breast lesion localization, thereby augmenting the global market growth. Furthermore, increasing mergers and acquisitions is also estimated to drive the global market development over the projected period. For instance, in January 2019, IZI Medical Products acquired select soft tissue biopsy and breast localization needle assets from Cook Medical. The acquisition is expected to expand product portfolio of IZI Medical Products with addition of MReye Breast Localization Coil.

The demand for breast cancer lesion localization products worldwide has significantly risen with the growing prevalence of breast cancer. Therefore, manufactures are expanding their product portfolio and geographical reach with increasing product launches and approvals. For instance, in March 2019, Hologic received CE certification for its LOCalizer wireless radiofrequency identification breast lesion localization system. The system is designed to replace wire-guided breast lesion localization technique. These manufacturers are further adopting numerous strategies, such as partnerships and acquisitions, to strengthen their positions in the global breast lesion localization methods market. For instance, in July 2018, Hologic Inc. announced that it completed the acquisition of Faxitron Bioptics, a privately held leader in digital specimen radiography, breast lesion localization, and sentinel lymph node biopsy.

Quick Buy – Breast Lesion Localization Methods Market Research Report: https://www.coherentmarketinsights.com/insight/buy-now/104

Key Market Takeaways:

• The key players operating in the global breast lesion localization methods market include Cook Medical Inc., Argon Medical Devices, Inc., Becton, Dickinson and Company (C. R. Bard), SOMATEX Medical Technologies GmbH, Sterylab Medical, Biopsybell Srl, Hologic Inc., and Tsunami S.r.l.
• As reported by the American Cancer Society, around 268,600 new cases of invasive breast cancer were diagnosed during 2019, and the incidence rate was seen to be increasing by 0.4% per year.
• Among techniques, the wire-guided localization segment exhibited the highest CAGR in the global breast lesion localization methods market in 2018, owing to the early establishment and higher adoption of this technique by various end-users.
• Among end-users, the hospitals segment held the leading position in the global breast lesion localization methods market in 2017, owing to the favorable reimbursement policies. As per the American Cancer Society, one-time screening mammogram every 12 months is covered fully under Medicare for all women aged above 40 years. The Medicare thus pays for clinical breast exam (CBE) once a year, for women with an average risk of breast cancer.

View Press Release For More Information @ https://www.coherentmarketinsights.com/press-release/breast-lesion-localization-methods-market-surpasses-us-10-billion-threshold-by-2024-103

Table of Contents

1. Research Objectives and Assumptions
   • Research Objectives
   • Assumptions
   • Abbreviations
2. Market Purview
   • Report Description
     • Market Definition and Scope
   • Executive Summary
     • Market Snippet, By Technique
     • Market Snippet, By End User
     • Market Snippet, By Region
   • Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
   • Market Dynamics
     • Drivers
     • Restraints
     • Market Opportunities
   • Impact Analysis
   • Key Developments
   • Industry Trends
   • Regulatory Scenario
   • Reimbursement Scenario
   • Epidemiology
   • PEST Analysis
4. Global Breast Lesion Localization Methods Market, By Technique, 2016 – 2027, (US$ Mn)
   • Introduction
     • Market Share Analysis, 2019 and 2027 (%)
     • Y-o-Y Growth Analysis, 2017 – 2027
     • Segment Trends
   • Wire Guided Localization
   • Radio Guided Occult Lesion Localization
   • Radioactive Seed Localization
   • Magnetic Tracers
   • Ultrasound-Guided Surgery
5. Global Breast Lesion Localization Methods Market, By End User, 2016 – 2027, (US$ Mn)
   • Introduction
     • Market Share Analysis, 2019 and 2027 (%)
     • Y-o-Y Growth Analysis, 2017 – 2027
     • Segment Trends
   • Hospitals
   • Specialized Clinics
   • Research Institutes
   • Ambulatory Surgical Centers
6. Global Breast Lesion Localization Methods Market, By Region, 2016 – 2027, (US$ Mn)
   • Introduction
     • Market Share Analysis, By Region, 2019 and 2027 (%)
     • Y-o-Y Growth Analysis, For Region, 2017–2026
   • North America
     • Market Size and Forecast, By Technique, 2016 – 2027, (US$ Mn)
     • Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
     • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
       • U.S.
       • Canada
   • Latin America
     • Market Size and Forecast, By Technique, 2016 – 2027, (US$ Mn)
     • Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
     • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
       • Brazil
       • Mexico
       • Argentina
       • Rest of Latin America
   • Europe
     • Market Size and Forecast, By Technique, 2016 – 2027, (US$ Mn)
     • Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
     • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
       • Germany
       • U.K.
       • France
       • Italy
       • Spain
       • Russia
       • Rest of Europe
   • Asia Pacific
     • Market Size and Forecast, By Technique, 2016 – 2027, (US$ Mn)
     • Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
     • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
       • China
       • India
       • Japan
       • Australia
       • South Korea
       • ASEAN
       • Rest of Asia Pacific
   • Middle East
     • Market Size and Forecast, By Technique, 2016 – 2027, (US$ Mn)
     • Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
     • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
       • GCC
       • Israel
       • Rest of Middle East
   • Africa
     • Market Size and Forecast, By Technique, 2016 – 2027, (US$ Mn)
     • Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
     • Market Size and Forecast, By Country/Region, 2016 – 2027, (US$ Mn)
       • South Africa
       • Central Africa
       • North Africa
7. Competitive Landscape
   • Company Profiles
     • Cook Medical Inc.
       • Company Overview
       • Product Portfolio
       • Financial Overview
       • Key Highlights
       • Market Strategies
     • Argon Medical Devices, Inc.
     • C. R. Bard, Inc.
     • SOMATEX Medical Technologies GmbH
     •  Sterylab Medical
     • Biopsybell Srl
     • Hologic Inc.
     • Tsunami S.r.l
8. Section
   • References
   • Research Methodology
   • About us and Sales Contact

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

To know more about us, please visit our website – www.coherentmarketinsights.com

Contact:

Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837